Maolac turns cow colostrum into patented health ingredients
The Series A biofunctional-ingredient company is one of 21 startups selected for ScaleUp House's inaugural cohort.
Maolac is one of the companies selected for the inaugural ScaleUp House cohort, joining the year-round program as it enters its next stage of international growth. The company develops clinically validated proteins and peptides from bovine colostrum for supplements, functional foods and beverages, with a focus on expanding its presence in global markets and building the foundations for its next phase of growth.
ID card
- Name: Maolac
- Industry: Pharma / BioTech
- Current Stage: A
- Founder Name: Maya Ashkenazi
- Year Founded: 2021
- Number of Employees: 20
Company Description
Maolac is a biofunctional ingredient company transforming bovine colostrum into clinically validated, high-value proteins and peptides for dietary supplements, functional foods and beverages. Its proprietary AI-powered platform identifies bioactives aligned with human biology and translates them into patented, formulation-ready ingredients targeting gut health, muscle recovery, healthy aging and general wellness. Maolac operates through a scalable B2B "Intel Inside" model, with commercial products already sold across multiple formats, customers and international markets. Following successful scientific and commercial validation, the company is expanding manufacturing capacity and global market access to lead the next generation of colostrum-based nutrition.
